Who Paid My Doc
Embeda
Drug Neuroscience;Pain
NDC 60793-430-20
General payments
$135,215
Research payments
$884,656
Through program year 2022, $135,215 in general payments and $884,656 in research payments were reported against Embeda (Neuroscience;Pain).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $15 | 1 |
| 2021 | Research | $1,214 | 2 |
| 2020 | General | $43 | 4 |
| 2020 | Research | $38,287 | 23 |
| 2019 | General | $135,157 | 11,384 |
| 2019 | Research | $845,155 | 29 |
Breakdown
Each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2022 where a state was reported.
Records
11,389 general · 54 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.